pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Marketed
    brigatinib
    Alunbrig (brigatinib)
    Non-Small Cell Lung Cancer Takeda Pharmaceuticals USA Inc
  • Phase 2
    brilacidin
    brilacidin
    Chemotherapy Induced Oral Mucositis Innovation Pharmaceuticals Inc
  • Phase 3
    brilaroxazine hydrochloride
    brilaroxazine hydrochloride
    Schizophrenia$RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC.
← prev
page 161 of 231
next →
131
Pain89
Neurology1
Preclinical
brimonidine
BRIMONIDINE
Glaucoma
TearClear Corp
  • Marketed
    brinzolamide
    Brinzolamide
    Ocular Hypertension Bausch Health US LLC
  • Phase 2
    briquilimab
    briquilimab
    Chronic Urticaria$JSPR Jasper Therapeutics, Inc.
  • Marketed
    brodalumab
    Siliq (brodalumab)
    Plaque Psoriasis (Psoriasis Vulgaris) Bausch Health US LLC
  • Phase 2
    brogidirsen
    brogidirsen
    Duchenne Muscular Dystrophy Nippon Shinyaku Co Ltd
  • Phase 3
    brolucizumab
    Beovu (brolucizumab)
    Proliferative Diabetic Retinopathy (PDR)$NVS NOVARTIS AG
  • Marketed
    bromelains
    NexoBrid (bromelains)
    Burns$MDWD MediWound Ltd.
  • Marketed
    bromfenac
    Bromfenac (bromfenac [INN])
    Ocular Pain (Eye Pain) Alembic Pharmaceuticals Inc
  • Marketed
    bromfenac sodium
    Bromfenac Sodium
    Ocular Pain (Eye Pain) Sentiss Pharmaceuticals LLC
  • Marketed
    bromocriptine mesylate
    Parlodel (bromocriptine mesylate)
    Amenorrhea Validus Pharmaceuticals LLC
  • Marketed
    brompheniramine maleate
    Veltane (brompheniramine maleate)
    Allergic Rhinitis Lannett Co Inc
  • Preclinical
    bucillamine
    bucillamine [INN]
    Post-Acute Sequelae of COVID 2019 (PASC or Long COVID) Revive Therapeutics Ltd
  • Preclinical
    bucillamine 1
    Ischemia Reperfusion Injury Revive Therapeutics Ltd
  • Phase 3
    bucindolol hydrochloride
    Gencaro (bucindolol hydrochloride)
    Atrial Fibrillation Genvara Biopharma Inc
  • Phase 2
    budoprutug
    budoprutug [INN]
    Membranous Glomerulonephritis$CLYM Climb Bio, Inc.
  • pre_registration
    bulevirtide
    bulevirtide
    Hepatitis D$GILD GILEAD SCIENCES, INC.
  • Phase 2
    buloxibutid sodium
    buloxibutid sodium
    Idiopathic Pulmonary Fibrosis Vicore Pharma AB
  • Phase 2
    bulumtatug fuvedotin
    bulumtatug fuvedotin [INN]
    Esophageal Squamous Cell Carcinoma (ESCC) Mabwell Shanghai Bioscience Co Ltd
  • Phase 3
    buntanetap tartrate
    buntanetap tartrate
    Parkinson's Disease$ANVS Annovis Bio, Inc.
  • Marketed
    bupivacaine hydrochloride
    Bupivacaine Hydrochloride
    Oral Mucositis OncoZenge AB
  • Phase 2
    bupropion
    bupropion
    Type 1 Narcolepsy (Narcolepsy with Cataplexy) Bioron Pharma
  • Marketed
    bupropion hydrobromide ER
    Aplenzin (bupropion hydrobromide)
    Major Depressive Disorder Bausch Health US LLC
  • Marketed
    burosumab
    Crysvita (burosumab-twza)
    X-Linked Hypophosphatemic Rickets$RARE Ultragenyx Pharmaceutical Inc.
  • Preclinical
    buspirone ER
    buspirone [INN]
    Unspecified Central Nervous System Disorders Mapi Pharma Ltd
  • Marketed
    butenafine hydrochloride
    Mentax (butenafine hydrochloride)
    Tinea Corporis Mylan Pharmaceuticals Inc
  • Marketed
    butoconazole nitrate
    Gynazole-1 (butoconazole nitrate)
    Vulvovaginal Candidiasis Padagis LLC
  • Marketed
    cabazitaxel
    Jevtana (cabazitaxel)
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Sanofi-Aventis US LLC